QuickTake:
At issue is whether therapeutic services using the psychedelic can be provided to homebound individuals who are unable to travel to a licensed treatment center. State attorneys opposed the idea.
A federal judge Monday, Nov. 16, heard arguments about whether psilocybin therapeutic treatments allowed under Oregon law — but now limited to licensed facilities — should also be provided to homebound individuals.
U.S. District Judge Mustafa Kasubhai said Monday he would rule within about 60 days, after considering federal law prohibiting discrimination against people with disabilities.
Psilocybin facilitators filed a June 2024 legal challenge seeking to expand access to those unable to travel by allowing in-home psilocybin treatments. The treatment would be administered by facilitators trained and licensed by the state.
“There’s no other way to provide services to this population other than in their homes, because they’re confined to their homes,” said Jordan Harris, an attorney representing the psilocybin facilitators.
Alexander Jones, an Oregon Department of Justice attorney, argued Monday that Oregon law makes clear that licensed facilitators can only administer the drug at regulated facilities.
Jones said the facilitators filing the legal challenge have shown no proof they are seeking a “reasonable modification.” He cited concerns about safety should the state be required to offer in-home treatments.
Twenty-two psilocybin service centers were operating in Oregon as of May, the state attorney said. He asserted the legal challenge to expand access should be denied for reasons including that it would not be a “reasonable alteration” to a state law.
The hearing was held at the University of Oregon School of Law, with students in attendance.
Kasubhai grilled attorneys about the Oregon Psilocybin Services Act, the law established by voters through Ballot Measure 109 in November 2020.
Harris argued that the “essence” of the law is not about safety or preventing the “dispersion” of psilocybin, but about having citizens be able to take psilocybin.
“The essence of the program is providing services to those who are eligible, and people who are eligible but for their disabilities. … They should be able to have these services,” Harris said.
Oregon is one of three states nationally with state-regulated adult access to psilocybin, also known as “shrooms” or “magic mushrooms,” according to the University of California, Berkeley’s Center for the Science of Psychedelics.
Ingesting psilocybin can cause people to experience visual and audio distortions and also can distort people’s sense of time and space, according to the National Institutes of Health.
The Oregon law states that psilocybin treatments can help with mental health conditions including end-of-life psychological distress.
The Oregon Health Authority previously denied requests made separately in 2023 by two licensed facilitators to administer psilocybin to homebound patients, according to court documents.

